- Wall Street is scrambling to have a stake in the company that cures coronavirus — and it has drug makers surging.
- That’s as the wider market marches towards its worst weekly performance since the financial crisis.
- Visit Business Insider’s homepage for more stories.
As equity indices head toward their worst week of losses since the financial crisis, investors have predictably begun placing bets on which company can produce a cure for the COVID-19 coronavirus at the root of the sell-off.
It’s becoming a crowded field.
In private markets, billionaire Jim Simons is betting millions on Codagenix, a small biotechnology company working on a read more >>>